Jefferies Financial Group Inc. Biogen Inc. Put Options Transaction History

Jefferies Financial Group Inc.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $3.97 Million - $4.97 Million	21,000 New	21,000 $4.07 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $24.2 Million - $27.6 Million	-94,400 Reduced 94.97%	5,000 $1.39 Million
Q4 2022 Sep 21, 2023	BUY	$252.44 - $306.72 $23.8 Million - $29 Million	94,400 Added 1888.0%	99,400 $27.5 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $25.1 Million - $30.5 Million	99,400 New	99,400 $27.5 Million

1,038

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.